BRITISH AMERICAN TOBACCO (BATS.L)

Executive Summary

British American Tobacco rebounded +3.16% to £4,472 since the June 4 report, partially recovering from the prior three-session selloff triggered by revised cigarette volume guidance. The stock has now stabilized following June 2's guidance adjustment, with the recovery supported by management's raised expectations for new-category revenue growth to mid-teens from low double-digits. While the investment thesis remains intact—transitioning from combustibles to smoke-free products—execution risks in Asia-Pacific and U.S. competitive pressures have increased near-term uncertainty, though the +6.12% YTD performance demonstrates resilience in a challenging operating environment.

Key Updates

BAT recovered +3.16% to £4,472 over the past four sessions, reversing approximately one-third of the -9.13% decline experienced following June 2's guidance revision. The stock now trades +6.12% YTD, maintaining positive momentum despite the recent volatility. The recovery suggests investors have digested the cigarette volume downgrade and are focusing on the positive offset from accelerating new-category growth. Trading volumes normalized following the initial selloff, indicating stabilization rather than capitulation. The £4,335-£4,472 range established over the past week represents a new consolidation zone as the market reassesses valuation in light of the mixed operational outlook.

Current Trend

BAT demonstrates a constructive YTD trend with +6.12% gains despite recent turbulence, supported by strong 1-month (+4.98%) and 6-month (+4.41%) performance. The stock reached eight-year highs in late May before the June 2 guidance revision triggered a sharp correction. Current price action suggests a basing pattern is forming around £4,350-£4,400, with the recent bounce to £4,472 testing initial resistance. The 5-day decline of -2.38% reflects residual selling pressure, though the 1-day gain of +1.54% indicates buyers are stepping in at current levels. Technical support appears established near £4,335, while resistance sits at the £4,591 level reached on May 27. The stock's ability to hold above £4,400 following negative news demonstrates underlying demand for the shares.

Investment Thesis

The investment thesis centers on BAT's strategic transformation from a traditional combustibles manufacturer to a diversified nicotine company with substantial exposure to high-growth smoke-free categories including vapes and nicotine pouches. Management maintains 3%-5% revenue growth and 4%-6% adjusted profit growth guidance at the lower end of medium-term ranges, indicating confidence in the overall business trajectory despite cigarette volume pressures. The company's new-category products are experiencing accelerating momentum, with revenue growth expectations raised to mid-teens from low double-digits, providing a critical growth engine as traditional cigarette volumes decline approximately 2.5% annually. This transition strategy balances near-term cash generation from combustibles—which continue delivering revenue and profit growth—with long-term positioning in reduced-risk alternatives. Valuation remains attractive relative to the stable cash flow profile and dividend yield, though execution risks in key markets require monitoring.

Thesis Status

The investment thesis remains fundamentally intact but faces near-term execution challenges that have increased risk premiums. The June 2 guidance adjustment—lowering cigarette volume expectations from -2% to -2.5% while raising new-category growth to mid-teens—validates the strategic direction but highlights regional weaknesses in Asia-Pacific, Middle East, and Africa alongside intensifying U.S. competitive pressures. Critically, management maintained full-year financial guidance, demonstrating that accelerating smoke-free revenue can offset combustible headwinds. The thesis assumes successful navigation of this transition, and recent developments confirm both the opportunity (strong new-category demand) and the challenge (faster-than-expected combustible decline in certain markets). Competitive dynamics have intensified, with Philip Morris's IQOS achieving top-100 global brand status and generating over $10 billion in annual revenues, underscoring the scale of opportunity but also the competitive threat BAT faces in smoke-free categories.

Key Drivers

The primary near-term driver remains execution on the smoke-free transition, with management accelerating the pivot to vapes and pouches in response to consumer demand. The revised guidance reflects two countervailing forces: declining combustible volumes, particularly in Asia-Pacific and due to U.S. competitive pressures as detailed in the June 2 announcement, offset by stronger-than-anticipated new-category adoption driving mid-teens revenue growth. Competitive positioning represents a critical factor, with PMI's IQOS serving 35 million users and achieving $10 billion in annual revenues within a decade, establishing a formidable benchmark for BAT's own smoke-free portfolio. Regulatory and reputational risks persist, as evidenced by criticism of PMI's marketing practices, which could foreshadow increased scrutiny across the sector. The broader industry context shows PMI targeting 66% smoke-free revenue by 2030, setting the pace for transformation that BAT must match or exceed to maintain competitive positioning.

Technical Analysis

BAT's chart structure shows a recovery from oversold conditions following the June 2 selloff, with the current £4,472 level representing a +3.16% bounce from the £4,335 support established on June 4. The stock peaked at £4,591 on May 27, marking eight-year highs before the guidance-driven correction. Key support now sits at £4,335-£4,350, representing the recent low and a logical stop-loss level for long positions. Resistance layers exist at £4,600 (prior high), with a breakout above this level potentially targeting the £4,750-£4,800 zone. The YTD gain of +6.12% outpaces broader market performance, though momentum indicators have cooled from overbought conditions reached in late May. Volume patterns suggest institutional accumulation near £4,350, providing a technical floor. The 6-month gain of +4.41% and 1-month advance of +4.98% demonstrate medium-term strength, while the 5-day decline of -2.38% reflects consolidation rather than trend reversal. A sustained move above £4,500 would signal renewed bullish momentum, while failure to hold £4,350 could trigger a retest of the £4,200 level.

Bull Case

• Accelerating smoke-free revenue growth: Management raised new-category revenue growth expectations to mid-teens from low double-digits, demonstrating stronger-than-anticipated consumer adoption of vapes and nicotine pouches, which provides a sustainable long-term growth engine as the company transitions away from combustibles. Source: Bloomberg
• Maintained financial guidance despite volume pressures: BAT affirmed its full-year 3%-5% revenue growth and 4%-6% adjusted profit growth targets, indicating that new-category strength can fully offset combustible headwinds and demonstrating management confidence in the business model's resilience. Source: Morningstar
• Strong technical momentum and multi-year breakout: The stock reached its highest levels since February 2018 in May, with YTD gains of +6.12% and recent support holding at £4,335, suggesting institutional accumulation and positive long-term sentiment despite near-term volatility. Source: Morningstar
• Continued combustible revenue and profit growth: Despite volume declines, BAT's combustible business continues generating revenue and profit momentum through pricing power and mix management, providing substantial cash flows to fund the smoke-free transition and shareholder returns. Source: Morningstar
• Large addressable market for reduced-risk products: Industry leader PMI has demonstrated the scale potential with IQOS generating over $10 billion annually and serving 35 million users within a decade, validating the commercial opportunity for BAT's smoke-free portfolio to capture meaningful market share. Source: Business Wire

Bear Case

• Accelerating combustible volume decline: BAT lowered its 2026 cigarette industry volume outlook to -2.5% from -2.0%, citing slower-than-expected progress in Asia-Pacific, Middle East, and Africa, indicating structural headwinds are intensifying faster than previously anticipated and threatening the core business cash generation. Source: Wall Street Journal
• Intensifying U.S. competitive pressure: Management specifically cited increased competitive pressure in the critical U.S. market, suggesting market share losses or margin compression in the world's most profitable tobacco market, which could materially impact overall profitability. Source: Morningstar
• PMI's commanding lead in smoke-free products: Philip Morris achieved 43% of Q1 2026 revenues from smoke-free products with IQOS recognized as a top-100 global brand serving 35 million users, demonstrating a significant competitive advantage that BAT must overcome to capture comparable market share and profitability in reduced-risk categories. Source: Business Wire
• Execution risk in Asia-Pacific markets: Management's acknowledgment of slower-than-anticipated progress in Asia-Pacific, Middle East, and Africa raises concerns about BAT's ability to compete effectively in high-growth emerging markets that are critical to long-term volume and revenue expansion. Source: Morningstar
• Regulatory and reputational risks: Industry criticism of tobacco companies' marketing practices, including accusations of targeting young consumers despite smoke-free commitments, could trigger increased regulatory scrutiny, advertising restrictions, or taxation that would pressure both combustible and new-category profitability. Source: The Guardian